Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NOVEL DRUG COMBINATIONS AND DONOR LYMPHOCYTE INFUSIONS ALLOW PROLONGED DISEASE CONTROL IN MULTIPLE MYELOMA PATIENTS RELAPSING AFTER ALLOGENEIC TRANSPLANT: New treatments for Multiple Myeloma patients relapsing after Allo transplant.
Nozzoli C, Pucillo M, Giaccone L, Rambaldi A, Stanghellini MTL, Benedetti E, Russo D, Mordini N, Mangiacavalli S, Bernasconi P, Parma M, Carluccio P, Galieni P, Rivela P, Martino M, Chiusolo P, Isola M, De Martino M, Oldani E, Degrandi E, Boncompagni R, Antonioli E, Carnevale F, Tozzi M, Selleri C, Fanin R, Patriarca F; Gruppo Italiano Trapianto Midollo Osseo (GITMO). Nozzoli C, et al. Among authors: rivela p. Transplant Cell Ther. 2024 Nov 4:S2666-6367(24)00744-9. doi: 10.1016/j.jtct.2024.10.015. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39505212
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial.
Cavallaro G, Grassi A, Pavoni C, Micò MC, Busca A, Cavattoni IM, Santarone S, Borghero C, Olivieri A, Milone G, Chiusolo P, Musto P, Saccardi R, Patriarca F, Pane F, Saporiti G, Rivela P, Terruzzi E, Cerretti R, Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Bernasconi P, Iori AP, Castagna L, Mordini N, Oldani E, Di Grazia C, Bacigalupo A, Rambaldi A. Cavallaro G, et al. Among authors: rivela p. Blood Cancer J. 2024 Aug 21;14(1):141. doi: 10.1038/s41408-024-01116-5. Blood Cancer J. 2024. PMID: 39168989 Free PMC article. Clinical Trial.
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice.
Tavarozzi R, Zacchi G, Pietrasanta D, Catania G, Castellino A, Monaco F, Gandolfo C, Rivela P, Sofia A, Schiena N, Bertassello C, Limberti G, Zallio F, Zanni M, Ladetto M. Tavarozzi R, et al. Among authors: rivela p. Cancers (Basel). 2023 Nov 13;15(22):5397. doi: 10.3390/cancers15225397. Cancers (Basel). 2023. PMID: 38001657 Free PMC article. Review.
The black swan: a case of central nervous system graft-versus-host disease.
Butera S, Tavarozzi R, Brunello L, Rivela P, Sofia A, Viero L, Salvio M, Ladetto M, Zallio F. Butera S, et al. Among authors: rivela p. J Basic Clin Physiol Pharmacol. 2023 Oct 17;34(6):805-809. doi: 10.1515/jbcpp-2023-0194. eCollection 2023 Nov 1. J Basic Clin Physiol Pharmacol. 2023. PMID: 37843253
The role of Bruton's kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinib.
Catania G, Tavarozzi R, Pini GM, Borra T, Gandolfo C, Zacchi G, Pietrasanta D, Monaco F, Zanni M, Lettieri M, Rivela P, Zallio F, Ladetto M. Catania G, et al. Among authors: rivela p. J Basic Clin Physiol Pharmacol. 2023 Apr 12;34(3):401-404. doi: 10.1515/jbcpp-2023-0051. eCollection 2023 May 1. J Basic Clin Physiol Pharmacol. 2023. PMID: 37040263
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia.
Tiacci E, Mancini A, Marchetti M, D'Elia GM, Candoni A, Morotti A, Romano A, Gozzetti A, Broccoli A, De Carolis L, Bruna R, Tisi MC, Selleri C, Capponi M, Vallisa D, Cattaneo C, Della Porta MG, Busca A, Falini B, Massaia M, Bertù L, Pulsoni A, Rivela P, Corradini P, Passamonti F. Tiacci E, et al. Among authors: rivela p. Br J Haematol. 2023 May;201(3):411-416. doi: 10.1111/bjh.18606. Epub 2022 Dec 20. Br J Haematol. 2023. PMID: 36541031 Free PMC article.
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.
Scarfò L, Heltai S, Albi E, Scarano E, Schiattone L, Farina L, Moia R, Deodato M, Ferrario A, Motta M, Reda G, Sancetta R, Coscia M, Rivela P, Laurenti L, Varettoni M, Perotta E, Capasso A, Ranghetti P, Colia M, Ghia P. Scarfò L, et al. Among authors: rivela p. Blood. 2022 Dec 1;140(22):2348-2357. doi: 10.1182/blood.2022016901. Blood. 2022. PMID: 35921541 Free article.
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs.
Vitale C, Salvetti C, Griggio V, Porrazzo M, Schiattone L, Zamprogna G, Visentin A, Vassallo F, Cassin R, Rigolin GM, Murru R, Laurenti L, Rivela P, Marchetti M, Pennese E, Gentile M, Boccellato E, Perutelli F, Montalbano MC, De Paoli L, Reda G, Orsucci L, Trentin L, Cuneo A, Tedeschi A, Scarfò L, Gaidano G, Mauro FR, Foà R, Boccadoro M, Coscia M. Vitale C, et al. Among authors: rivela p. Blood. 2021 Jun 24;137(25):3507-3517. doi: 10.1182/blood.2020008201. Blood. 2021. PMID: 33651883 Free article. Clinical Trial.